The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Cervical Cancer (v2024.0).

Autor: Sznurkowski JJ; Profesor Sznurkowski Podmiot Leczniczy, ul. Stefana Żeromskiego 23A, 81-246 Gdynia, Poland., Bodnar L; Faculty of Medical Sciences and Health Sciences, University of Siedlce, 08-110 Siedlce, Poland.; Department of Clinical Oncology and Radiotherapy, Siedlce Cancer Center, 08-110 Siedlce, Poland., Szylberg Ł; Department of Tumor Pathology and Pathomorphology, Oncology Centre Prof. Franciszek Łukaszczyk Memorial Hospital, 85-796 Bydgoszcz, Poland.; Department of Obstetrics, Gynecology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-168 Bydgoszcz, Poland., Zołciak-Siwinska A; Department of Gynecological Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Dańska-Bidzińska A; Department of Gynecologic Oncology, Second Clinic of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland., Klasa-Mazurkiewicz D; Department of Obstetrics and Gynecological Oncology, Medical University of Gdańsk, 80-210 Gdańsk, Poland., Rychlik A; Department of Gynecological Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Kowalik A; Department of Molecular Diagnostics, Holy Cross Cancer Center, 25-734 Kielce, Poland.; Division of Medical Biology, Institute of Biology, Jan Kochanowski University, 25-406 Kielce, Poland., Streb J; Department of Oncology, Jagiellonian University Medical College, 31-008 Krakow, Poland., Bidziński M; Department of Gynecological Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland., Sawicki W; Department of Obstetrics and Gynecological Oncology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Publikováno v: Journal of clinical medicine [J Clin Med] 2024 Jul 25; Vol. 13 (15). Date of Electronic Publication: 2024 Jul 25.

The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma (2023).

Autor: Sznurkowski JJ; Department of Surgical Oncology, Medical University of Gdansk, ul. Smoluchowskiego 17, 80-214 Gdańsk, Poland., Rys J; Department of Tumor Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków Branch, 44-102 Kraków, Poland., Kowalik A; Department of Molecular Diagnostics, Holy Cross Cancer Center, 25-735 Kielce, Poland.; Division of Medical Biology, Institute of Biology, Jan Kochanowski University, 25-406 Kielce, Poland., Zolciak-Siwinska A; Department of Gynaecological Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 00-001 Warsaw, Poland., Bodnar L; Faculty of Medical and Health Sciences, Siedlce University of Natural Sciences and Humanities, 08-110 Siedlce, Poland., Chudecka-Glaz A; Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, 70-111 Szczecin, Poland., Blecharz P; Department of Gynaecologic Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, 44-102 Kraków, Poland., Zielinska A; Department of Obstetrics and Gynecological Oncology, Medical University of Warsaw, 00-575 Warsaw, Poland., Marszalek A; Department of Tumor Pathology and Prophylaxis, Poznan University of Medical Sciences, 61-701 Poznan, Poland.; Department of Tumor Pathology, Greater Poland Cancer Center in Poznan, 61-866 Poznan, Poland., Bidzinski M; Department of Gynaecological Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 00-001 Warsaw, Poland., Sawicki W; Department of Obstetrics and Gynecological Oncology, Medical University of Warsaw, 00-575 Warsaw, Poland.

Publikováno v: Journal of clinical medicine [J Clin Med] 2023 Feb 13; Vol. 12 (4). Date of Electronic Publication: 2023 Feb 13.

Prognostic factors in patients with vulvar cancer: the VULCAN study.

Autor: Zapardiel I; Gynecologic Oncology Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain., Iacoponi S; Gynecologic Oncology Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain., Coronado PJ; Gynecology Department, Hospital Clinico Universitario San Carlos - IdISSC, Madrid, Spain pcoronadom@sego.es., Zalewski K; Gynecologic Oncology Department, Maria Sklodowska-Curie Memorial Cancer Center - Institute of Oncology, Warsaw, Poland., Chen F; Department of Gynecology, Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Germany., Fotopoulou C; Department of Gynecology, Campus Virchow-Klinikum, Charite Universitatsmedizin Berlin, Berlin, Germany., Dursun P; Department of Obstetrics and Gynecology Division of Gynecologic Oncology, Baskent University School of Medicine, Ankara, Turkey., Kotsopoulos IC; Gynecological Oncology Department, Theagenio Cancer Hospital, Thessaloniki, Greece., Jach R; Gynecology Department, University Hospital, Jagiellonian University, Krakow, Poland., Buda A; Gynecologic Oncology Department, Hospital San Gerardo, Monza, Lombardia, Italy., Martinez-Serrano MJ; Gynecologic Oncology Unit, Vall d'Hebron Institut d'Oncologia, Barcelona, Spain., Grimm C; Division of General Gynaecology and Gynaecological Oncology, Medical University of Vienna - Vienna General Hospital, Vienna, Austria., Fruscio R; Gynecologic Oncology Department, Hospital San Gerardo, Monza, Lombardia, Italy., Garcia E; Gynecologic Oncology Department, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain., Sznurkowski JJ; Department of Surgical Oncology, Medical University of Gdańsk, Gdańsk, Poland., Ruiz C; Gynecologic Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain., Noya MC; Gynecology Department, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain., Barazi D; Gynecologic Oncology Department, Ciudad Sanitaria de Bellvitge, Barcelona, Spain., Diez J; Gynecologic Oncology Department, Hospital de Cruces, Vizcaya, Spain., Diaz De la Noval B; Gynecology Department, Hospital Universitario Central de Asturias, Spain., Bartusevicius A; Gynecologic Oncology Department, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania., De Iaco P; Gynecology Department, Policlinico S. Orsola-Malpighi, Bologna, Italy., Otero M; Gynecology Department, Complejo Hospitalario de Leon, Leon, Spain., Diaz M; Gynecology Department, Complejo Hospitalario Universitario Juan Canalejo, La Coruña, Spain., Haidopoulos D; Gynecologic Oncology, Alexandra Hospital, Athens, Greece., Franco S; Gynecology Department, Hospital Vall D'Hebron, Barcelona, Spain., Blecharz P; Gynecologic Oncology Department, Maria Sklodowska-Curie Memorial Cancer Center, Krakow, Poland., Zuñiga MA; Gynecology Department, Complejo Hospitalario Torrecardenas, Almeria, Spain., Rubio P; Gynecology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Gardella B; Gynecologic Oncology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Papatheodorou DC; Gynecology Department, Metaxa Memorial Cancer Hospital, Athens, Greece., Yildirim Y; Gynecologic Oncology Department, Ege Gynaecology Training and Research Hospital, Izmir, Turkey., Fargas F; Gynecology Department, Instituto Universitario Dexeus, Barcelona, Spain., Macuks R; Gynecologic Oncology Department, Riga East Clinical University Hospital Latvian Oncology Center, Riga, Latvia.

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2020 Sep; Vol. 30 (9), pp. 1285-1291. Date of Electronic Publication: 2020 Jun 22.

Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma.

Autor: Sznurkowski JJ; Department of Oncological Surgery, The Medical University, Gdańsk, Poland., Żawrocki A; Department of Pathology, The Medical University, Gdańsk, Poland., Biernat W; Department of Pathology, The Medical University, Gdańsk, Poland.

Publikováno v: Oncotarget [Oncotarget] 2017 Jul 11; Vol. 8 (28), pp. 46204-46210.

The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.

Autor: Sznurkowski JJ; Department of Surgical Oncology, The Medical University of Gdańsk, ul. Smoluchowskiego 17, 80-214, Gdańsk, Poland. jacek.sznurkowski@gumed.edu.pl., Żawrocki A; Department of Pathology, The Medical University of Gdańsk, ul. Smoluchowskiego 17, 80-214, Gdańsk, Poland., Biernat W; Department of Pathology, The Medical University of Gdańsk, ul. Smoluchowskiego 17, 80-214, Gdańsk, Poland.

Publikováno v: BMC cancer [BMC Cancer] 2016 Jul 13; Vol. 16, pp. 465. Date of Electronic Publication: 2016 Jul 13.